Shionogi Pharma, CIMA LAB sue Mylan
Shionogi Pharma and CIMA LABS filed the lawsuit in the US District Court for the District of Delaware. The product is the generic version of Orapred ODT, a
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The Scopius-5 database platform stores many details of selected compounds such as: multiple-conformation 3D models, shape and charge descriptors, property values and compound availability information, and/or synthetic route